Refine by
Hereditary Disease Equipment & Supplies
4 equipment items found
by:LIXTE Biotechnology Holdings, Inc. based inPasadena, CALIFORNIA (USA)
Designated as our LB-200 series of compounds, these have potential use in the prevention and treatment of neurodegenerative diseases. The series has the potential to be the most effective in its class and may be useful for the treatment of chronic hereditary diseases, such as Gaucher’s disease, in addition to cancer and ...
by:Astraveus based inParis, FRANCE
Hematopoietic stem cells (HSCs) are mothers to all blood cells including erythrocytes and lymphocytes. We develop high quality genetically edited HSCs to cure an undisclosed hereditary blood disease. This development will be translatable: genetically edited HSCs can be used to treat multiple genetic diseases, including hemoglobinopathies and ...
by:Gain Therapeutics, Inc. based inBethesda, MARYLAND (USA)
GM1 Gangliosidosis is a hereditary, progressive disease mostly impacting neurons in the brain and spinal cord, caused by mutations in GLB1, the gene that encodes the beta-galactosidase (GLB) enzyme. These mutations result in the misfolding and subsequent dysfunction of GLB, which leads to the toxic substrate accumulation of GM1 ganglioside in organs and tissues. ...
by:The Regeneration Center based inBangkok, THAILAND
Cord blood refers to blood left in the umbilical cord after birth. Back in the day, this was generally discarded. However, because of modern advances in regenerative medical sciences, scientists have found a very useful purpose for them. The goal now is preservation or application of cord blood instead of discarding them. Why? Because it has been found to be rich in mesenchymal stem ...